| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/01/2007 | WO2006061723B1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 03/01/2007 | WO2003086277A3 Attenuated gram negative bacteria |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049550 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049519 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048333 CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes |
| 03/01/2007 | US20070048331 Non-toxic mutants of pathogenic gram-negative bacteria |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 03/01/2007 | US20070048329 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | DE102005039154A1 Bioabbaubare Polymere für den Transport von Nukleinsäuren in Zellen Biodegradable polymers for the delivery of nucleic acids into cells |
| 03/01/2007 | CA2620125A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 03/01/2007 | CA2619863A1 Use of ambroxol for the treatment of rhinovirus infections |
| 02/28/2007 | EP1757937A2 Antagonists of HMG1 for treating inflammatory conditions |
| 02/28/2007 | EP1757697A2 Group B streptococcus antigens |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757609A1 Novel water-soluble prodrug |
| 02/28/2007 | EP1757598A1 Substituted pyrrolidine derivative |
| 02/28/2007 | EP1757304A1 Pharmaceutical composition and its use for the prophylactic or therapeutic treatment of retroviral diseases |
| 02/28/2007 | EP1757303A1 Human lysozyme medicine, its manufacturing method and application thereof |
| 02/28/2007 | EP1757277A1 Oral preparations and process for production thereof |
| 02/28/2007 | EP1756133A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1 |
| 02/28/2007 | EP1756103A2 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756041A2 Polycationic compounds and uses thereof |
| 02/28/2007 | EP1755664A2 Prrsv subunit vaccines |
| 02/28/2007 | EP1755663A2 Neisserial vaccines |
| 02/28/2007 | EP1755628A1 Lactic bacteria and their use in the prevention of diarrhea |
| 02/28/2007 | EP1755576A1 Antimicrobial compositions and methods for their use |
| 02/28/2007 | EP1622880B1 Substituted dihydrochinazolines having antiviral properties |
| 02/28/2007 | EP1615629A4 Peptide deformylase inhibitors |
| 02/28/2007 | EP1501795B1 Cinnamic acid amides |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1436002B1 Use of peptide vectors to improve the immune response to antigens |
| 02/28/2007 | EP1406642B1 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 02/28/2007 | EP1401493B1 Subunit vaccines and processes for the production thereof |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1296696B1 Herbal composition containing calendula and eucalyptus for the treatment and curing of diseases |
| 02/28/2007 | EP1296685B1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1254240B1 Hybrid protease with reduced antigenicity and its use |
| 02/28/2007 | EP1079802B1 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention |
| 02/28/2007 | EP1024827B1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 02/28/2007 | EP0938497B1 Constrained helical peptides and methods of making same |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 02/28/2007 | CN1922191A Crystal of oxacephem |
| 02/28/2007 | CN1922190A 3-pyridinium methylcephem compound |
| 02/28/2007 | CN1922179A Crystalline forms of valacyclovir hydrochloride |
| 02/28/2007 | CN1922178A Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921884A Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| 02/28/2007 | CN1921867A Nucleoside phosphonate derivatives useful in the treatment of HIV infections |
| 02/28/2007 | CN1920045A Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response |
| 02/28/2007 | CN1920041A Reconstruction of HIV-1 Chinese epidemic strain gag gene and recombination DNA vaccine thereof |
| 02/28/2007 | CN1919870A Cat alpha interferon, encode gene and application thereof |
| 02/28/2007 | CN1919860A Synthesis of 2'-deoxy-l-nucleosides |
| 02/28/2007 | CN1919859A Synthesis of 2'-deoxy-l-nucleosides |
| 02/28/2007 | CN1919858A Synthesis of 2'-deoxy-l-nucleosides |
| 02/28/2007 | CN1919846A Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 02/28/2007 | CN1919341A Application of hepatitis B surface antigen-antibody complexes in preparing prophylaxis product with no response or low response to hepatitis B vaccine |
| 02/28/2007 | CN1919340A Hydrophobia split vaccine for human body |
| 02/28/2007 | CN1919291A Decoction medicine for treating verruca acuminata and its preparing process |
| 02/28/2007 | CN1919286A Traditional medicine composition, its preparation and usage |
| 02/28/2007 | CN1919274A Stellera chamaejasme injection for treating animal hair tinea disease and its preparation method |
| 02/28/2007 | CN1919270A Composition, exract, and pharmaceutical use thereof |
| 02/28/2007 | CN1919263A Medicine for treating diarrhoea |
| 02/28/2007 | CN1919221A Natural product extract, preparation method and uses thereof |
| 02/28/2007 | CN1919217A Capsule made of ant extract, spirulina platensis dry powder and chinese caterpillar fungus extract |
| 02/28/2007 | CN1919214A Monascus soft capsule and its preparation method |
| 02/28/2007 | CN1919213A Monascus pellet and its preparing method |
| 02/28/2007 | CN1919211A Bee glue paste for treating parotiditis |
| 02/28/2007 | CN1919205A Pharmaceutical composition comprising oxymatrine and baicalin |
| 02/28/2007 | CN1919194A Liquid composition of sirolimus |
| 02/28/2007 | CN1919192A Curcumenol self-emulsifying capsule and preparation method thereof |
| 02/28/2007 | CN1919169A Penciclovir emulsifiable paste and its preparation |
| 02/28/2007 | CN1301998C New process for the preparation of vinyl pyrrolidinone cephalosporine derivatives |
| 02/28/2007 | CN1301994C Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |